These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21051394)

  • 21. Time to define the disorders of the syndrome of COPD.
    Beasley R; Weatherall M; Travers J; Shirtcliffe P
    Lancet; 2009 Aug; 374(9691):670-2. PubMed ID: 19716947
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of FEV6 in the detection of airway obstruction.
    Demir T; Ikitimur HD; Koc N; Yildirim N
    Respir Med; 2005 Jan; 99(1):103-6. PubMed ID: 15672857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of forced expiratory volume in 6 seconds (FEV(6)) in the evaluation of pulmonary function in Chinese elderly males].
    Pan MM; Zhang HS; Sun TY
    Zhonghua Yi Xue Za Zhi; 2017 May; 97(20):1556-1561. PubMed ID: 28592061
    [No Abstract]   [Full Text] [Related]  

  • 24. Flawed interpretative strategies for lung function tests harm patients.
    Enright P
    Eur Respir J; 2006 Jun; 27(6):1322-3; author reply 1323-4. PubMed ID: 16772397
    [No Abstract]   [Full Text] [Related]  

  • 25. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6.
    Vandevoorde J; Verbanck S; Schuermans D; Kartounian J; Vincken W
    Eur Respir J; 2006 Feb; 27(2):378-83. PubMed ID: 16452596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Point: Is an increase in FEV₁ and/or FVC ≥ 12% of control and ≥ 200 mL the best way to assess positive bronchodilator response? Yes.
    Pellegrino R; Brusasco V
    Chest; 2014 Sep; 146(3):536-537. PubMed ID: 25180717
    [No Abstract]   [Full Text] [Related]  

  • 27. Predicting an accelerated lung function decline in smokers: is there a proper threshold?
    Mohamed Hoesein FA; Zanen P
    Eur Respir J; 2014 Jan; 43(1):307-8. PubMed ID: 24381323
    [No Abstract]   [Full Text] [Related]  

  • 28. Predicting an accelerated lung function decline in smokers: is there a proper threshold?
    Akkermans RP; Biermans M; Robberts B; ter Riet G; Jacobs A; van Weel C; Wensing M; Schermer T
    Eur Respir J; 2014 Jan; 43(1):308-9. PubMed ID: 24381324
    [No Abstract]   [Full Text] [Related]  

  • 29. COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers.
    Akkermans RP; Biermans M; Robberts B; ter Riet G; Jacobs A; van Weel C; Wensing M; Schermer T
    Eur Respir J; 2014 Jan; 43(1):54-63. PubMed ID: 23563262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A method to derive lower limit of normal for the FEV1/forced expiratory volume at 6 s of exhalation ratio from FEV1/FVC data.
    Capderou A; Berkani M; Becquemin MH; Zelter M
    Chest; 2009 Feb; 135(2):408-418. PubMed ID: 18812448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Concave Shape of the Forced Expiratory Flow-Volume Curve in 3 Seconds Is a Practical Surrogate of FEV
    Li H; Liu C; Zhang Y; Xiao W
    Respir Care; 2017 Mar; 62(3):363-369. PubMed ID: 27999150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measuring slow vital capacity to detect airflow limitation in a woman with dyspnea and a preserved FEV1/FVC ratio.
    Berton DC; Neder JA
    J Bras Pneumol; 2019 Apr; 45(2):e20190084. PubMed ID: 31038657
    [No Abstract]   [Full Text] [Related]  

  • 33. Changes in respiratory function impairment following the treatment of severe pulmonary tuberculosis - limitations for the underlying COPD detection.
    Radovic M; Ristic L; Ciric Z; Dinic-Radovic V; Stankovic I; Pejcic T; Rancic M; Bogdanovic D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1307-16. PubMed ID: 27366058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abandoning FEV(1)/FVC < 0.70 to detect airway obstruction: an essential debate but with the right emphasis?
    Robberts B; Schermer T
    Chest; 2011 May; 139(5):1253-1254. PubMed ID: 21540228
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulmonary Artery Abnormalities in Ex-smokers with and without Airflow Obstruction.
    Lindenmaier TJ; Kirby M; Paulin G; Mielniczuk L; Cunningham IA; Mura M; Licskai C; Parraga G
    COPD; 2016; 13(2):224-34. PubMed ID: 26606693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FEV3, FEV6 and their derivatives for detecting airflow obstruction in adult Chinese.
    Lam DC; Fong DY; Yu WC; Ko FW; Lau AC; Chan JW; Choo KL; Mok TY; Tam CY; Ip MS; Chan-Yeung MM
    Int J Tuberc Lung Dis; 2012 May; 16(5):681-6. PubMed ID: 22507932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Flow Decay: A Novel Spirometric Index to Quantify Dynamic Airway Resistance.
    Oh A; Morris TA; Yoshii IT; Morris TA
    Respir Care; 2017 Jul; 62(7):928-935. PubMed ID: 28559470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluctuations and determinism of respiratory impedance in asthma and chronic obstructive pulmonary disease.
    Muskulus M; Slats AM; Sterk PJ; Verduyn-Lunel S
    J Appl Physiol (1985); 2010 Dec; 109(6):1582-91. PubMed ID: 20813978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.
    Swanney MP; Ruppel G; Enright PL; Pedersen OF; Crapo RO; Miller MR; Jensen RL; Falaschetti E; Schouten JP; Hankinson JL; Stocks J; Quanjer PH
    Thorax; 2008 Dec; 63(12):1046-51. PubMed ID: 18786983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.
    Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA
    Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.